United States
Germany
Japan
United Kingdom
China
SLC9A1 (NM_003047) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC214890L4V
- LentiORF®
-
Lenti ORF particles, SLC9A1 (mGFP-tagged) - Human solute carrier family 9 (sodium/hydrogen exchanger), member 1 (SLC9A1), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 16,720.00
货期*
详询
规格
Product images
经常一起买 (3)
Specifications
| Product Data | |
| Product Name | SLC9A1 (NM_003047) Human Tagged ORF Clone Lentiviral Particle |
| Synonyms | APNH; LIKNS; NHE-1; NHE1; PPP1R143 |
| Vector | pLenti-C-mGFP-P2A-Puro |
| ACCN | NM_003047 |
| ORF Size | 2445 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC214890).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_003047.2 |
| RefSeq Size | 4516 bp |
| RefSeq ORF | 2448 bp |
| Locus ID | 6548 |
| Protein Families | Druggable Genome, Transmembrane |
| Protein Pathways | Cardiac muscle contraction, Regulation of actin cytoskeleton |
| MW | 90.6 kDa |
| Gene Summary | This gene encodes a Na+/H+ antiporter that is a member of the solute carrier family 9. The encoded protein is a plasma membrane transporter that is expressed in the kidney and intestine. This protein plays a central role in regulating pH homeostasis, cell migration and cell volume. This protein may also be involved in tumor growth. [provided by RefSeq, Sep 2011] |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
You may also need
Customer
Reviews
Loading...
